Fang Zhu

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy

Yongmei Yin, Yanhong Gu, R. Guo, 2016, Drug design, development and therapy.

Prognostic value of perioperative leukocyte count in resectable gastric cancer.

R. Guo, Y. Shu, O. Røe, 2016, World journal of gastroenterology.

Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer

B. Jiang, Y. Shu, Jitai Zheng, 2014, PloS one.

ObRb downregulation increases breast cancer cell sensitivity to tamoxifen

Yongmei Yin, Y. Shu, Jinrong Qiu, 2015, Tumor Biology.

Pre-adjuvant chemotherapy leukocyte count may predict the outcome for advanced gastric cancer after radical resection.

Y. Shu, Yi-qian Liu, Xiaofeng Chen, 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.